© 2020 MJH Life Sciences and AJMC. All rights reserved.
© 2020 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
November 05, 2018
A community-based care management program for high-risk patients reduced hospital readmissions and also likely reduced admissions and Medicare parts A and B spending.
November 06, 2018
“Frequent flyers” significantly contribute to emergency department (ED) crowding. This study developed a predictive model that can be used to identify high-risk patients and reduce ED revisits.
November 07, 2018
We found race and age disparities not only in who adopted patient portal technology but also in which features were accessed by those who were adopters.
November 08, 2018
Alzheimer disease and other dementias (ADOD) have a substantial impact on the prevalence and costs of certain comorbid conditions compared with matched beneficiaries without ADOD.
November 09, 2018
A cancer pain control program for inpatients based on electronic health record–based automatic screening provided effective pain relief and achieved high satisfaction among patients and physicians.
November 12, 2018
LETTERS TO THE EDITORS
This letter argues that an editorial published in the August 2018 issue provides an unduly limited perspective of the impact of Choosing Wisely.
November 13, 2018
New value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.
November 15, 2018
This pharmacist-led, patient-directed intervention demonstrated a reduction in opioid dispensings in the 90 days following hip replacement but not knee replacement.
November 14, 2018
The mean 24-week cost per participant was $5416 for extended-release injectable naltrexone (57% detoxification, 37% medication, 6% provider/patient) and $4148 for buprenorphine-naloxone (64% detoxification, 12% medication, 24% provider/patient).
November 16, 2018
TRENDS FROM THE FIELD
Among veterans in Massachusetts, receipt of opioids from multiple sources, with or without benzodiazepines, was associated with worse opioid-related outcomes.
From The Editorial Board